Tjerk S.J. Opstal

Colchicine in Patients with Chronic Coronary Disease

Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics

Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom et al. · American Heart Journal · 2019 · 102 citations

Cardiovascular Disease, Low-dose Colchicine, Pharmacology +9

Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy

Max J. M. Silvis, Aernoud T.L. Fiolet, Tjerk S.J. Opstal et al. · Atherosclerosis · 2021 · 60 citations · Full text

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven et al. · Journal of the American College of Cardiology · 2021 · 52 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Atherosclerosis +6

Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein

Aernoud T.L. Fiolet, Max J. M. Silvis, Tjerk S.J. Opstal et al. · PLoS ONE · 2020 · 50 citations · Full text